Skip to main content
Enterprise AI Analysis: Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

0 Overall Accuracy in Distinguishing prePMF from ET
Feature Real Images (Agreement) Generated ET Images (Agreement)
AI Prediction Agreement 76.0% 12.0%

Enterprise Process Flow

Digitized H&E Bone Marrow Biopsy Slides
Train AI for diagnosis prediction of prePMF vs ET
Generate synthetic histology to identify novel morphology
Correlate predictions on real and generated images
0 Higher Adipose Tissue in ET Images

AI's Novel Feature Identification

Our AI model uncovered that the proportion of adipose tissue is a significant differentiator between ET and prePMF, a feature not explicitly prioritized in traditional diagnostic criteria. This suggests AI can leverage subtle morphological cues beyond what human experts typically focus on. This discovery was amplified through the use of generated images, which exaggerated these differences, making them more apparent.

Improving Diagnostic Certainty

Accurate differentiation between prePMF and ET is crucial due to differing prognostic outcomes and treatment approaches. PrePMF carries a higher risk of transformation to overt myelofibrosis and leukemia. Our AI tool offers a valuable aid, especially in centers with lower MPN patient volumes, enhancing diagnostic certainty and potentially improving clinical trial enrollment by refining patient cohorts.

Calculate Your Potential ROI

Understand the economic impact AI can have on your diagnostic workflows and operational efficiency.

Annual Savings Potential $0
Hours Reclaimed Annually 0

Our Streamlined Implementation Roadmap

We ensure a smooth, efficient integration of AI into your existing workflows, maximizing impact with minimal disruption.

Phase 1: Discovery & Strategy

In-depth assessment of current processes, data infrastructure, and specific diagnostic challenges to define clear AI objectives.

Phase 2: Data Integration & Model Training

Secure integration of your de-identified histology data, followed by custom model training and validation using our advanced AI framework.

Phase 3: Pilot Deployment & Refinement

Staged deployment of the AI tool within a controlled environment, gathering feedback for iterative refinement and optimization.

Phase 4: Full Scale Integration & Support

Seamless integration into your clinical systems, accompanied by comprehensive training and ongoing technical support.

Ready to Transform Your Diagnostic Workflow?

Connect with our AI specialists to explore how our solutions can provide clarity and efficiency in complex diagnostic areas like MPNs.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking